Management of 'refractory' skin disease in patients with lupus erythematosus

Best Practice and Research: Clinical Rheumatology

Volumn 19, Issue 5 SPEC. ISS., 2005, Pages 767-784

  Callen, Jeffrey P ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Cutaneous lupus; Discoid lupus erythematosus; Subacute cutaneous lupus erythematosus

Indexed keywords

AURANOFIN; CALCIPOTRIOL; CALCIUM CHANNEL BLOCKING AGENT; CEFUROXIME; CHLOROQUINE; CORTICOSTEROID DERIVATIVE; COSMETIC; CYTARABINE; CYTOKINE; CYTOTOXIC AGENT; DAPSONE; ETRETIN; HYDROCHLOROTHIAZIDE; HYDROXYCHLOROQUINE; IMIQUIMOD; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; ISOTRETINOIN; MEPACRINE; PHENYTOIN; PIMECROLIMUS; RETINOIC ACID; RETINOID DERIVATIVE; RIDURA; SULFALAZINE; SUNSCREEN; TACROLIMUS; TAZAROTENE; TERBINAFINE; THALIDOMIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

BLOOD TOXICITY; BRAIN PSEUDOTUMOR; CLINICAL FEATURE; CLINICAL TRIAL; CRYOTHERAPY; DEPRESSION; DIARRHEA; DISCOID LUPUS ERYTHEMATOSUS; DISEASE CLASSIFICATION; DIZZINESS; DOSE RESPONSE; DROWSINESS; DRUG EFFICACY; DRUG ERUPTION; DRUG INDUCED DISEASE; DRUG INDUCED HEADACHE; DRUG MEGADOSE; DRUG SAFETY; EYE TOXICITY; HISTOPATHOLOGY; HUMAN; HYPERLIPIDEMIA; HYPERPIGMENTATION; HYPOPIGMENTATION; IMMUNOFLUORESCENCE TEST; LICHENOID ERUPTION; LIVER TOXICITY; LOW DRUG DOSE; LOW LEVEL LASER THERAPY; MYOPATHY; NAUSEA; NEUROPATHY; OVARY INSUFFICIENCY; PANNICULITIS; PATHOGENESIS; PATIENT EDUCATION; PHOTOSENSITIVITY; PRIORITY JOURNAL; PROGNOSIS; PROTECTIVE CLOTHING; PRURITUS; PSYCHOSIS; RELAPSE; RETINOPATHY; REVIEW; RISK BENEFIT ANALYSIS; SKIN BIOPSY; SKIN CANCER; SKIN IRRITATION; SKIN LUPUS ERYTHEMATOSUS; SKIN PROTECTION; SMOKING CESSATION; SUN EXPOSURE;

EID: 24344484732     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.berh.2005.05.003     Document Type: Review

References (78)

1. J.P. Callen Management of skin disease in patients with lupus erythematosus Best Practice and Research: Clinical Rheumatology 16 2002 313-332
2. M. Srivastava A. Rencic G. Diglio et al. Drug-induced, Ro/SSA-positive cutaneous lupus erythematosus Archives of Dermatology 139 2003 45-49
3. J.P. Callen How frequently are drugs associated with the development or exacerbation of subacute cutaneous lupus? Archives of Dermatology 139 2003 89-90
4. M. Shapiro A.C. Sosis J.M. Junkins-Hopkins V.P. Werth Lupus erythematosus induced by medications, ultraviolet radiation, and other exogenous agents: A review, with special focus on the development of subacute cutaneous lupus erythematosus in a genetically predisposed individual International Journal of Dermatology 43 2004 87-94
5. N. Scheinfeld V.A. Deleo Photosensitivity in lupus erythematosus Photodermatology, Photoimmunology and Photomedicine 20 2004 272-279
6. P. Lehmann E. Holze P. Kind et al. Experimental reproduction of skin lesions in lupus erythematosus by UVA and UVB radiation Journal of the American Academy of Dermatology 22 1990 181-187
7. E.M. Tan A.S. Cohen J.F. Fries et al. The revised criteria for the classification of systemic lupus erythematosus Arthritis and Rheumatism 25 11 1982 1271-1277
8. V.C. Fabre S. Lear M. Reichlin et al. Twenty percent of biopsy specimens from sun-exposed skin of normal young adults demonstrate positive immunofluorescence Archives of Dermatology 127 1991 1006-1011
9. J.P. Callen Therapy of cutaneous lupus erythematosus Dermatologic Therapy 14 2001 61-69
10. J.P. Callen Update on the management of cutaneous lupus erythematosus The British Journal of Dermatology 151 2004 731-736
11. M. Heath G.J. Raugi Evidence-based evaluation of immunomodulatory therapy of cutaneous manifestations of lupus Advances in Dermatology 20 2004 257-291
12. S. Jessop D. Whitelaw F. Jordaan Drugs for discoid lupus erythematosus Cochrane Database of Systematic Reviews 1 2001 CD002954
13. B.R. Reed J.C. Huff S.K. Jones et al. Subacute cutaneous lupus erythematosus associated with hydrochlorothiazide therapy Annals of Internal Medicine 103 1985 49-51
14. A.N. Crowson C.M. Magro Subacute cutaneous lupus erythematosus arising in the setting of calcium channel blocker therapy Human Pathology 28 1997 67-73
15. J.P. Callen C.L. Kulp-Shorten A.P. Hughes Subacute cutaneous lupus erythematosus induced or exacerbated by terbinafine: A report of 5 cases Archives of Dermatology 137 9 2001 1196-1198
16. H. Gallego C.E. Crutchfield III E.J. Lewis H.J. Gallego Report of an association between discoid lupus erythematosus and smoking Cutis 63 1999 231-234
17. H. Stege M.A. Budde S. Grether J. Krutmann Evaluation of the capacity of sunscreens to photoprotect lupus erythematosus patients by employing the photoprovocation test Photodermatology, Photoimmunology and Photomedicine 16 2000 256-259
18. T. Herzinger G. Plewig M. Röcken Use of sunscreens to protect against ultraviolet-induced lupus erythematosus Arthritis and Rheumatism 50 2004 3045-3046
19. C.E. Lampropoulos S. Sangle P. Harrison et al. Topical tacrolimus therapy of resistant cutaneous lesion in lupus erythematosus: A possible alternative Rheumatology 43 2004 1383-1385
20. M. Böhm M. Gaubitz T.A. Luger et al. Topical tacrolimus as a therapeutic adjunct in patients with cutaneous lupus erythematosus Dermatology 207 2003 381-385
21. A. Kreuter T. Gambichler F. Breuckmann et al. Pimecrolimus 1% cream for cutaneous lupus erythematosus Journal of the American Academy of Dermatology 51 2004 407-410
22. R. Gerdsen J. Wenzel M. Uerlich et al. Successful treatment of chronic discoid lupus erythematosus of the scalp with imiquimod Dermatology 205 2002 416-418
23. T.B. Neiwold W.I. Swedler Systemic lupus erythematosus arising during interferon-alpha therapy for cyroglobulinemic vasculitis associated with hepatitis C Clinical Rheumatology 2004 [Epub ahead of print]
24. L. Molin M. Tarstedt Discoid lupus erythematosus treated with cryotherapy The Journal of Dermatological Treatment 14 2003 182-183
25. A. Kuhn P.M. Becker-Wegerich T. Ruzicka P. Lehmann Successful treatment of discoid lupus erythematosus with argon laser Dermatology 201 2000 175-177
26. O. Baniandrés P. Boiseda P. Belmar A. Pérez Treatment of lupus erythematosus with pulsed dye laser Lasers Surg Med 32 2003 327-330
27. P. Rahman D.D. Gladman M.B. Urowitz Smoking interferes with efficacy of antimalarial therapy in cutaneous lupus Journal of Rheumatology 25 1998 1716-1719
28. M.L. Jewell D.P. McCauliffe Patients with cutaneous lupus erythematosus who smoke are less responsive to antimalarial treatment Journal of the American Academy of Dermatology 42 2000 983-987
29. R. Feldmann D. Salomon J.-H. Saurat The association of the two antimalarials chloroquine and quinacrine for treatment-resistant chronic and subacute cutaneous lupus erythematosus Dermatology 189 1994 425-427
30. D. Lipsker J.-C. Piette P. Cacoub et al. Chloroquine-quinacrine association in resistant cutaneous lupus Dermatology 190 1995 257-258
31. E. Toubi I. Rosner M. Rozenbaum et al. The benefit of combining hydroxychloroquine with quinacrine in the treatment of SLE patients Lupus 9 2000 92-95
32. A. Fielder E. Graham S. Jones et al. Royal College of Ophthalmologists guidelines: Ocular toxicity and hydroxychloroquine Eye 12 1998 907-909
33. J.P. Callen Chronic cutaneous lupus erythematosus. Clinical, laboratory, therapeutic and prognostic examination of 62 patients Archives of Dermatology 118 1982 412-416
34. P.R. Coburn S. Shuster Dapsone and discoid lupus erythematosus The British Journal of Dermatology 106 1982 105-106
35. R. Lindskov F. Reymann Dapsone in the treatment of cutaneous lupus erythematosus Dermatologica 172 1986 214-217
36. T Ruzicka G Goerz Dapsone in the treatment of lupus erythematosus British Journal of Dermatology 104 1981 53-56
37. D.A. Fenton M.M. Black Low-dose dapsone in the treatment of subacute cutaneous lupus erythematosus Clinical and Experimental Dermatology 11 1986 102-103
38. R.P. Hall T.J. Lawley H.R. Smith S.I. Katz Bullous eruption of systemic lupus erythematosus: Dramatic response to dapsone therapy Annals of Internal Medicine 97 1982 165-170
39. J. Holtman D. Neustadt J.P. Callen Dapsone is an effective therapy for the skin lesions of Subacute cutaneous lupus erythematosus and urticarial vasculitis in a patient with C2 deficiency Journal of Rheumatology 17 1990 122-125
40. R. Neri M. Mosca E. Bernacchi S. Bombardieri A case of SLE with acute, subacute and chronic cutaneous lesions successfully treated with dapsone Lupus 8 1999 240-243
41. J.F.C. Krivanek W.K.A. Paver S. Kossard G. Cains Clofazimine (lamprene) in the treatment of discoid lupus erythematosus The Australasian Journal of Dermatology 17 1976 108-110
42. J.F.C. Krivanek W.K.A. Paver Further study of the use of clofazimine in discoid lupus erythematosus The Australasian Journal of Dermatology 21 1980 169-171
43. L. Rudnicka E. Szymanska I. Walecka M. Stowinska Long-term cefuroxime axetil in subacute cutaneous lupus erythematosus. A report of three cases Dermatology 200 2000 129-131
44. E. Delaporte B. Catteau N. Sabbagh et al. Traitment du lupus erythemateux chronique par la sulfasalazine: 11 observations Annales de Dermatologie et de Venereologie 124 1997 151-156
45. S. Lagrange J.-C. Piette P.-A. Becherel et al. Sulfasalazine in the treatment of cutaneous lupus erythematosus: Open trial in six cases Lupus 7 1998 21
46. K. Dalziel G. Going P.H. Cartwright et al. Treatment of chronic discoid lupus erythematosus with an oral gold compound (Auranofin) The British Journal of Dermatology 115 1986 211-216
47. B. Stenjker Auranofin in the treatment of discoid lupus erythematosus The Journal of Dermatological Treatment 2 1991 27-29
48. K.Q. Lu S. Brenneman R. Burns Jr et al.Thalidomide inhibits UVB-induced mouse keratinocytes apoptosis by both TNF-a-dependent and TNF-a-independent pathways Photodermatology, Photoimmunology and Photomedicine 19 2003 272-280
49. D.L. Cummins A.A. Gaspari Photoprotection by thalidomide in patients with chronic cutaneous and systemic lupus erythematosus: Discordant effects on minimal erythema dose and sunburn cell formation The British Journal of Dermatology 151 2004 458-464
50. E. Atra E.I. Sato Treatment of cutaneous lesions of systemic lupus erythematosus with thalidomide Clinical and Experimental Rheumatology 11 1993 487-493
51. J.D. Duong T. Spigel R.T. Moxley III A.A. Gaspari American experience with low-dose thalidomide therapy for severe cutaneous lupus erythematosus Archives of Dermatology 135 1999 1079-1087
52. T.S. Housman J.L. Jorizzo M.A. McCarty et al. Low-dose thalidomide therapy for refractory cutaneous lesions of lupus erythematosus Archives of Dermatology 139 2003 50-54
53. S. Bastuji-Garin S. Ochonisky P. Bouche et al. Incidence and risk factors for thalidomide neuropathy: A prospective study of 135 dermatologic patients The Journal of Investigative Dermatology 119 2002 1020-1026
54. M.T. Pelle V.P. Werth Thalidomide in cutaneous lupus erythematosus American Journal of Clinical Dermatology 4 2003 379-387
55. M.A. Rodriquez-Castellanos J.B. Rubio J.F.B. Gomez A.G. Mendoza Phenytoin in the treatment of discoid lupus erythematosus Archives of Dermatology 131 1995 620-621
56. R.C. Newton J.L. Jorizzo A.R. Solomon et al. Mechanism-oriented assessment of isotretinoin in chronic of subacute cutaneous lupus erythematosus Archives of Dermatology 122 1986 180-186
57. B.B. Furner Subacute cutaneous lupus erythematosus response to isotretinoin International Journal of Dermatology 29 1990 587-590
58. T. Ruzicka M. Meurer O. Brown-Falco Treatment of cutaneous lupus erythematosus with etretinate Acta Dermato-Venereologica 65 1985 324-329
59. L.S. Green D. Saperia N.J. Lowe M. David Coexistent psoriasis and lupus erythematosus: Successful therapy with etretinate The Journal of Dermatological Treatment 1 1989 19-22
60. J.P. Callen L.V. Spencer J.B. Burruss J. Holtman Azathioprine: An effective, corticosteroids-sparing therapy for patients with recalcitrant cutaneous lupus erythematosus or with recalcitrant cutaneous leukocytoclastic vasculitis Archives of Dermatology 127 1991 515-522
61. C.G. Tsokos S.W. Caughman J.H. Klippel Successful treatment of generalized discoid skin lesions with azathioprine. Its use in a patient with systemic lupus erythematosus Archives of Dermatology 121 1985 1323-1325
62. R. Ashinoff V.P. Werth A.G. Franks Jr Resistant discoid lupus erythematosus of palms and soles: Successful treatment with azathioprine Journal of the American Academy of Dermatology 19 1988 961-965
63. E. Goldstein W. Carey Discoid lupus erythematosus: Successful treatment with oral methotrexate Archives of Dermatology 130 1994 938-939
64. W.W. Bottomley M. Goodfield Methotrexate for the treatment of severe mucocutaneous lupus erythematosus The British Journal of Dermatology 133 1995 311-314
65. I.B. Boehm G.A. Boehm R. Bauer Management of cutaneous lupus erythematosus with low-dose methotrexate: Indication for modulation of inflammatory mechanisms Rheumatology International 18 1998 59-62
66. N.M. Hanjani C.H. Nousari Mycophenolate mofetil for the treatment of cutaneous lupus erythematosus with smoldering systemic involvement Archives of Dermatology 138 2002 1616-1618
67. S. Schanz A. Ulmer G. Rassner G. Fierlbeck Successful treatment of subacute cutaneous lupus erythematosus with mycophenolate mofetil The British Journal of Dermatology 147 2002 174-178
68. R.L. Yung B.C. Richardson Cytarabine therapy for refractory cutaneous lupus erythematosus Arthritis and Rheumatism 38 1995 1341-1343
69. E.J. Schulz M.A. Menter Treatment of discoid and subacute cutaneous lupus erythematosus with cyclophosphamide The British Journal of Dermatology 85 1971 60-65
70. F. Heule T. vanJoost R. Beukers Cyclosporine in the treatment of lupus erythematosus Archives of Dermatology 122 1986 973-974
71. J.A. Yell S.M. Burge Cyclosporin and discoid lupus erythematosus The British Journal of Dermatology 131 1994 132-133
72. V.D. Lernia G. Bisighini Discoid lupus erythematosus during treatment with cyclosporine Acta Dermato-Venereologica 76 1996 87-88
73. M. Goodfield K. Davison K. Bowden Intravenous immunoglobulin (IVIg) for therapy-resistant cutaneous lupus erythematosus (LE) The Journal of Dermatological Treatment 15 2004 46-50
74. T. Genereau O. Chosidow C. Danel et al. High-dose intravenous immunoglobulin in cutaneous lupus erythematosus Archives of Dermatology 135 1999 1124-1125
75. B. Fautrel V. Foltz C. Frances et al. Regression of subacute cutaneous lupus erythematosus in a patient with rheumatoid arthritis treated with a biologic tumor necrosis factor alpha-blocking agent Arthritis and Rheumatism 46 2002 1408-1409
76. J.-F. Nicolas J. Thivolet J. Kanitkis S. Lyonnet Response of discoid and subacute cutaneous lupus erythematosus to recombinant interferon alpha 2a The Journal of Investigative Dermatology 95 1990 142S-145S
77. B. Tebbe M. Lauy H. Gollnick Therapy of cutaneous lupus erythematosus with recombinant interferon alpha-2a European Journal of Dermatology 2 1992 253-255
78. J.C. Prinz et al. Treatment of severe cutaneous lupus erythematosus with a chimeric CD4 monoclonal antibody, cM-T412 Journal of the American Academy of Dermatology 34 1996 244-252